Clinical correlates of CSF Aβ42 and tau in patients with mild cognitive impairment

被引：0
|
作者：
Schoonenboom, NS
Visser, PJ
Van Elk, EJ
Lindeboom, J
Mulder, C
Scheltens, P
机构：
[1] VU Univ Med Ctr, Alzheimer Ctr, Dept Neurol, Amsterdam, Netherlands
[2] VU Univ Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
[3] VU Univ Med Ctr, Alzheimer Ctr, Dept Psychol, Amsterdam, Netherlands
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81190-4
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [1] CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment
    Herukka, SK
    Hallikainen, M
    Soininen, H
    Pirttilä, T
    NEUROLOGY, 2005, 64 (07) : 1294 - 1297
  • [2] The combination of CSF Ab42 and Tau or Phospho-Tau predict progression in patients with mild cognitive impairment
    Pirttilä, T
    Herukka, S
    Hallikainen, M
    Soininen, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S297 - S298
  • [3] CSF Tau protein correlates with cognitive impairment in multiple sclerosis patients at diagnosis
    Virgilio, Eleonora
    Vecchio, Domizia
    Crespi, Ilaria
    Barbero, Paolo
    Galli, Giulia
    Cantello, Roberto
    Dianzani, Umberto
    Comi, Cristoforo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [4] Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
    H Hampel
    S J Teipel
    T Fuchsberger
    N Andreasen
    J Wiltfang
    M Otto
    Y Shen
    R Dodel
    Y Du
    M Farlow
    H-J Möller
    K Blennow
    K Buerger
    Molecular Psychiatry, 2004, 9 : 705 - 710
  • [5] Value of CSF β-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
    Hampel, H
    Teipel, SJ
    Fuchsberger, T
    Andreasen, N
    Wiltfang, J
    Otto, M
    Shen, Y
    Dodel, R
    Du, Y
    Farlow, M
    Möller, HJ
    Blennow, K
    Buerger, K
    MOLECULAR PSYCHIATRY, 2004, 9 (07) : 705 - 710
  • [6] CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
    Montine, Thomas J.
    Shi, Min
    Quinn, Joseph F.
    Peskind, Elaine R.
    Craft, Suzanne
    Ginghina, Carmen
    Chung, Kathryn A.
    Kim, Hojoong
    Galasko, Douglas R.
    Jankovic, Joseph
    Zabetian, Cyrus P.
    Leverenz, James B.
    Zhang, Jing
    MOVEMENT DISORDERS, 2010, 25 (15) : 2682 - 2685
  • [7] CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
    Li, G.
    Sokal, I.
    Quinn, J. F.
    Leverenz, J. B.
    Brodey, M.
    Schellenberg, G. D.
    Kaye, J. A.
    Raskind, M. A.
    Zhang, J.
    Peskind, E. R.
    Montine, T. J.
    NEUROLOGY, 2007, 69 (07) : 631 - 639
  • [8] Clinical correlates of hippocampal atrophy in patients with mild cognitive impairment
    Grundman, M
    Kim, HT
    Schultz, AN
    Thomas, RG
    Thal, L
    Jack, CR
    Peterson, RC
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S364 - S364
  • [9] Incipient Alzheimer's disease in patients with mild cognitive impairment can be detected by CSF levels of total tau, phospho tau and Ab42
    Andreasen, N
    Winblad, B
    Blennow, K
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 324 - 324
  • [10] CSF phosphorylated tau protein and mild cognitive impairment: a prospective study
    Arai, H
    Ishiguro, K
    Ohno, H
    Moriyama, M
    Itoh, N
    Okamura, N
    Matsui, T
    Morikawa, Y
    Horikawa, E
    Kohno, H
    Sasaki, H
    Imahori, K
    EXPERIMENTAL NEUROLOGY, 2000, 166 (01) : 201 - 203
12345